| 1 |
Grugni G, Sartorio A, Crino A. Growth hormone therapy for Prader-willi syndrome: challenges and solutions. Ther Clin Risk Manag 2016;12:873-81.
|
| 2 |
Kuppens RJ, Mahabier EF, Bakker NE, Siemensma EP, Donze SH, Hokken-Koelega AC. Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial. Orphanet J Rare Dis 2016;11:153.
DOI
|
| 3 |
Hokken-Koelega A, van der Lely AJ, Hauffa B, Hausler G, Johannsson G, Maghnie M, et al. Bridging the gap: metabolic and endocrine care of patients during transition. Endocr Connect 2016;5:R44-54.
DOI
|
| 4 |
Hoybye C, Hilding A, Jacobsson H, Thoren M. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome. Clinical Endocrinology 2003; 58:653-61.
DOI
|
| 5 |
Mogul HR, Lee PD, Whitman BY, Zipf WB, Frey M, Myers S, et al. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial. Journal of Clinical Endocrinology and Metabolism 2008;93:1238-45.
DOI
|
| 6 |
Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, et al. Body composition, endocrine and metabolic profiles in adults with Prader-Willi Syndrome. Growth Hormone and IGF Research 2010;20:179-84.
DOI
|
| 7 |
Deal C, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS and the 2011 GH in PWS Clinical Care Guidelines Workshop Participants. Growth hormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2013;98: E1072-78.
DOI
|
| 8 |
Molinas C, Cazals L, Diene G, Glattard M, Arnaud C, Tauber M; French Reference Centre for PWS (FrRefC-PWS). French database of children and adolescents with Prader- Willi syndrome. BMC Medical Genetics 2008;9:89.
|
| 9 |
Kido Y, Sakazume S, Abe Y, Oto Y, Itabashi H, Shiraishi M, et al. Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome: an observational study. Am J Med Genet A 2013;161A:2167-73.
|
| 10 |
Grugni G, Marzullo P. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome. Best Pract Res Clin Endocrinol Metab 2016;30:785-94.
DOI
|
webmaster
